trial

Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia

NCTId NCT00455663
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 105 (actual)
Sponsored by The University of Texas Health Science Center at San Antonio
Primary completion 2006-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
105 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2000-11
Primary completion
2006-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Cognitive Adaptation TrainingPharm-Cognitive Adaptation Training

Sponsors

The University of Texas Health Science Center at San AntonioLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Dawn I. Velligan, PhDPrincipal Investigator

Sites

1 total
San Antonio, United States

Facts & assertions

4 sourced
Enrollment
105
Phase
NA
Primary Completion Date
2006-01
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive Adaptation Training
drug
Pharm-Cognitive Adaptation Training
drug
lead_sponsor
The University of Texas Health Science Center at San Antonio
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizophrenia
indication
Medication Adherence
indication
investigator
Dawn I. Velligan, PhD
person